Ascend Wellness Holdings AAWH
OTC AAWH
$0.43 +0.03 (+6.26%)
At close: Aug 19, 2026 · 3:11 PM UTC

Ascend Wellness Holdings (AAWH) Non Operating Income (2020 - 2026)

Ascend Wellness Holdings (AAWH) posted quarterly Non Operating Income of -$20.1 million for Q1 2026, down 87.92% year-over-year from -$166.7 million in Q1 2025, and down 31.62% quarter-over-quarter from -$15.3 million in Q4 2025.

Ascend Wellness Holdings (AAWH) Non Operating Income (2020 - 2026) Analysis & Trends

Ascend Wellness Holdings' Non Operating Income history runs 7 years deep, the most recent figure standing at -$20.1 million for Q1 2026.

  • In Q1 2026, Non Operating Income fell 87.92% year-over-year to -$20.1 million; the TTM figure through Mar 2026 stood at -$59.2 million (down 25.89% YoY), while the FY2025 annual figure was -$49.8 million, down 11.78% from the prior year.
  • Non Operating Income for Q1 2026 stood at -$20.1 million, down from -$15.3 million in the prior quarter.
  • The five-year high for Non Operating Income was $13.6 million in Q2 2023, with the low at -$20.1 million in Q1 2026.
  • The 5-year median for Non Operating Income is -$8.7 million (2023), against an average of -$9.3 million.
  • The sharpest annual moves came in 2023 and 2024: Non Operating Income jumped 249.13% in 2023, then tumbled 160.13% in 2024.
  • Ascend Wellness Holdings' Non Operating Income stood at -$8.5 million in 2022, then grew by 6.63% to -$7.9 million in 2023, then plunged by 52.53% to -$12.1 million in 2024, then fell by 26.4% to -$15.3 million in 2025, then tumbled by 31.62% to -$20.1 million in 2026.
  • Business Quant data shows AAWH's Non Operating Income at -$20.1 million in Q1 2026, -$15.3 million in Q4 2025, and -$12.2 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Haleon 43.91 Bn 42.95 Bn - -
2 Teva Pharmaceutical Industries 43.15 Bn 39.49 Bn 2.15 Bn -224.00 Mn
3 Zoetis 31.52 Bn 29.84 Bn 1.05 Bn 5.00 Mn
4 Takeda Pharmaceutical 28.58 Bn 22.78 Bn 5.10 Bn -
5 United Therapeutics 22.16 Bn 19.50 Bn 683.80 Mn 41.90 Mn
6 Viatris 18.76 Bn 17.87 Bn 1.46 Bn -
7 Neurocrine Biosciences 15.48 Bn 15.09 Bn 935.80 Mn 10.70 Mn
8 Elanco Animal Health 11.69 Bn 11.16 Bn 798.00 Mn -
9 Dr Reddys Laboratories 10.13 Bn 9.96 Bn - -
10 Ascend Wellness Holdings 98.46 Mn 31.46 Mn 45.49 Mn -20.81 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -20.81 Mn
Mar 31, 2026 -20.13 Mn
Dec 31, 2025 -15.30 Mn
Sep 30, 2025 -12.22 Mn
Jun 30, 2025 -11.57 Mn
Mar 31, 2025 -10.71 Mn
Dec 31, 2024 -12.10 Mn
Sep 30, 2024 -16.07 Mn
Jun 30, 2024 -8.16 Mn
Mar 31, 2024 -8.23 Mn
Dec 31, 2023 -7.93 Mn
Sep 30, 2023 -8.06 Mn
Jun 30, 2023 13.56 Mn
Mar 31, 2023 -8.71 Mn
Dec 31, 2022 -8.50 Mn
Sep 30, 2022 -8.16 Mn
Jun 30, 2022 -9.10 Mn
Mar 31, 2022 -5.93 Mn
Dec 31, 2021 -7.34 Mn
Sep 30, 2021 -12.33 Mn